{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:08:01Z","timestamp":1784689681542,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","award":["ISSN 2666-6367"],"award-info":[{"award-number":["ISSN 2666-6367"]}],"id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012285","name":"BC Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcyt.2026.102062","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:57:24Z","timestamp":1768409844000},"page":"102062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL"],"prefix":"10.1016","volume":"28","author":[{"given":"Madeline P.","family":"Lauener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Normand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayeh","family":"Abdossamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1799-1053","authenticated-orcid":false,"given":"Elena","family":"Ostroumov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0305-5790","authenticated-orcid":false,"given":"Megan K.","family":"Levings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3191-7263","authenticated-orcid":false,"given":"Karen","family":"Sherwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Fenninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Keown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Dieud\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0001-6438","authenticated-orcid":false,"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102062_bib0001","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5045\/br.2015.50.4.194","article-title":"Hematopoietic stem cell expansion and generation: the ways to make a breakthrough","volume":"50","author":"Park","year":"2015","journal-title":"Blood Res"},{"key":"10.1016\/j.jcyt.2026.102062_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102062_bib0003","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102062_bib0004","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1158\/1078-0432.CCR-14-0586","article-title":"Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia","volume":"21","author":"Boyiadzis","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.jcyt.2026.102062_bib0005","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2015-09-668251","article-title":"Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells","volume":"127","author":"Kariminia","year":"2016","journal-title":"Blood."},{"issue":"15","key":"10.1016\/j.jcyt.2026.102062_bib0006","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood.2019003186","article-title":"Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE\/PBMTC 1202 studies","volume":"135","author":"Schultz","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jcyt.2026.102062_bib0007","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3324\/haematol.2017.170928","article-title":"CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results","volume":"102","author":"Kariminia","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102062_bib0008","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3324\/haematol.2022.280653","article-title":"CD56bright CD16- natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease","volume":"108","author":"Lauener","year":"2023","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102062_bib0009","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.immuni.2023.08.004","article-title":"Infection induces tissue-resident memory NK cells that safeguard tissue health","volume":"56","author":"Schuster","year":"2023","journal-title":"Immunity."},{"issue":"6","key":"10.1016\/j.jcyt.2026.102062_bib0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.humimm.2019.03.003","article-title":"B cells in chronic graft-versus-host disease","volume":"80","author":"McManigle","year":"2019","journal-title":"Hum Immunol"},{"issue":"21","key":"10.1016\/j.jcyt.2026.102062_bib0011","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-222190","article-title":"NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects","volume":"115","author":"Olson","year":"2010","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jcyt.2026.102062_bib0012","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1182\/bloodadvances.2022007715","article-title":"A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE\/PBMTC 1202 study","volume":"7","author":"Cuvelier","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2026.102062_bib0013","first-page":"212","volume":"27","author":"Molligoda Arachchige","year":"2021"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102062_bib0014","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92111","article-title":"An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition","volume":"2","author":"Forcade","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2026.102062_bib0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2019.02.001","article-title":"The role of cytokines in the regulation of NK cells in the tumor environment","volume":"117","author":"Konjevi\u0107","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.jcyt.2026.102062_bib0016","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fimmu.2016.00606","article-title":"Regulatory Functions of Natural Killer Cells in Multiple Sclerosis","volume":"7","author":"Gross","year":"2016","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102062_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026173","article-title":"IL-27 imparts immunoregulatory function to human NK cell subsets","volume":"6","author":"Laroni","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102062_bib0018","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4049\/jimmunol.180.2.850","article-title":"Regulatory NK cells suppress antigen-specific T cell responses","volume":"180","author":"Deniz","year":"2008","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102062_bib0019","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jcyt.2024.07.013","article-title":"Expansion and characterization of immune suppressive CD56(bright)Perforin(-) regulatory-like natural killer cells in chronic graft-versus-host disease","volume":"26","author":"Lauener","year":"2024","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102062_bib0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12026-015-8664-y","article-title":"Practical NK cell phenotyping and variability in healthy adults","volume":"62","author":"Angelo","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.jcyt.2026.102062_bib0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5045\/kjh.2011.46.2.80","article-title":"The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma","volume":"46","author":"Min","year":"2011","journal-title":"Korean J Hematol"},{"key":"10.1016\/j.jcyt.2026.102062_bib0022","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.148.9.2953","article-title":"Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation","volume":"148","author":"Murphy","year":"1992","journal-title":"J Immunol"},{"issue":"5562","key":"10.1016\/j.jcyt.2026.102062_bib0023","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2026.102062_bib0024","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI1268","article-title":"Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation","volume":"101","author":"Asai","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2026.102062_bib0025","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2006-05-024315","article-title":"Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors","volume":"109","author":"Lundqvist","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102062_bib0026","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood.V82.7.2216.2216","article-title":"Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation","volume":"82","author":"Soiffer","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102062_bib0027","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bmt.1704165","article-title":"Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors","volume":"32","author":"Yamasaki","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102062_bib0028","first-page":"86","article-title":"Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease","volume":"90","author":"Abrahamsen","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2026.102062_bib0029","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/bmt.2008.432","article-title":"KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12\/12 HLA matched, hematopoietic stem cell transplantation","volume":"44","author":"Ludajic","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102062_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbmt.2009.10.021","article-title":"The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings","volume":"16","author":"Clausen","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102062_bib0031","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2010-10-316125","article-title":"Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT","volume":"117","author":"Sivori","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102062_bib0032","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102062_bib0033","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s00018-011-0799-y","article-title":"Insights into NK cell biology from human genetics and disease associations","volume":"68","author":"Wood","year":"2011","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"10.1016\/j.jcyt.2026.102062_bib0034","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"Shi","year":"2011","journal-title":"Nature Rev. Immunol."},{"key":"10.1016\/j.jcyt.2026.102062_bib0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaut.2012.05.006","article-title":"Regulatory NK cells in autoimmune disease","volume":"39","author":"Tian","year":"2012","journal-title":"J Autoimmun"},{"issue":"1950","key":"10.1016\/j.jcyt.2026.102062_bib0036","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.1100789","article-title":"Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis","volume":"187","author":"Jiang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2026.102062_bib0037","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.it.2005.08.008","article-title":"NK cells: elusive players in autoimmunity","volume":"26","author":"Johansson","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jcyt.2026.102062_bib0038","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.autrev.2008.03.002","article-title":"NK cells in autoimmunity: a two-edg'd weapon of the immune system","volume":"7","author":"Perricone","year":"2008","journal-title":"Autoimmunity Rev"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102062_bib0039","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.immuni.2023.01.016","article-title":"Infection induces tissue-resident memory NK cells that safeguard tissue health","volume":"56","author":"Schuster","year":"2023","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.jcyt.2026.102062_bib0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jcyt.2026.102062_bib0041","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1590\/S1679-45082013000200019","article-title":"Current data on IL-17 and Th17 cells and implications for graft versus host disease","volume":"11","author":"Normanton","year":"2013","journal-title":"Einstein (Sao Paulo)"},{"key":"10.1016\/j.jcyt.2026.102062_bib0042","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2021.09.009","article-title":"PD-1, CTLA-4, LAG-3, and TIGIT: The roles of immune checkpoint receptors on the regulation of human NK cell phenotype and functions","volume":"240","author":"Esen","year":"2021","journal-title":"Immunol Lett"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102062_bib0043","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-018-0217-9","article-title":"LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII","volume":"19","author":"Maruhashi","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcyt.2026.102062_bib0044","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2026.102062_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fimmu.2018.00015","article-title":"TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis","volume":"9","author":"Chyuan","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.jcyt.2026.102062_bib0046","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102062_bib0047","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4049\/jimmunol.1000108","article-title":"Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology","volume":"185","author":"Ernst","year":"2010","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102062_bib0048","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2020.1744568","article-title":"TGF-beta: a master immune regulator","volume":"24","author":"Larson","year":"2020","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102062_bib0049","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41417-021-00352-2","article-title":"Cytokine-enhanced cytolytic activity of exosomes from NK Cells","volume":"29","author":"Enomoto","year":"2022","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102062_bib0050","doi-asserted-by":"crossref","first-page":"eaah7152","DOI":"10.1126\/sciimmunol.aah7152","article-title":"Eomesodermin promotes the development of type 1 regulatory T (TR1) cells","volume":"2","author":"Zhang","year":"2017","journal-title":"Sci Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:17:09Z","timestamp":1782199029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1465324926000186"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102062","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102062"}}